Akumin to Go Private in Deal With PE Firm Stonepeak

Dow Jones

2023/10/21

By Ben Glickman

Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case.

Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin.

The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations.

Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock.

The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure.

Write to Ben Glickman at ben.glickman@wsj.com

(END) Dow Jones Newswires

October 20, 2023 17:18 ET (21:18 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2377226502"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2377226502\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2377226502?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-10-21 05:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2377226502","market":"us","top_or_hot":-1,"title":"Akumin to Go Private in Deal With PE Firm Stonepeak","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Ben Glickman \n</p>\n<pre>\n \n</pre>\n<p>\n  Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case. \n</p>\n<p>\n  Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin. \n</p>\n<p>\n  The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations. \n</p>\n<p>\n  Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock. \n</p>\n<p>\n  The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Ben Glickman at ben.glickman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 20, 2023 17:18 ET (21:18 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akumin to Go Private in Deal With PE Firm Stonepeak</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkumin to Go Private in Deal With PE Firm Stonepeak\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2023-10-21 05:18</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Ben Glickman \n</p>\n<pre>\n \n</pre>\n<p>\n  Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case. \n</p>\n<p>\n  Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin. \n</p>\n<p>\n  The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations. \n</p>\n<p>\n  Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock. \n</p>\n<p>\n  The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Ben Glickman at ben.glickman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 20, 2023 17:18 ET (21:18 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健護理服務","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2377226502","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2377226502","pubTimestamp":1697836680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case.Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin.The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations.Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock.The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","AKUMQ":"Akumin Inc."},"translate_title":"阿库敏将与私募股权公司Stonepeak进行私有化交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKUMQ":0.9,"AKU":0.9},"content_text":"By Ben Glickman \n\n\n \n\n\n  Akumin agreed to be taken private by private-equity firm Stonepeak in a prepackaged chapter 11 case. \n\n\n  Plantation, Fla.-based Akumin said Stonepeak's note, totaling $470 million, would be cancelled and converted to shares of Akumin. Stonepeak will also invest $130 million into Akumin. \n\n\n  The outpatient radiology and oncology company said it expected court approval for the deal within 45 days with no disruption of operations. \n\n\n  Current Akumin shareholders will receive $25 million in cash and certain contingent value rights for their stock. \n\n\n  The company announced in August that its board had formed a committee to explore strategic initiatives related to its capital structure. \n\n\n \n\n\n  Write to Ben Glickman at ben.glickman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 20, 2023 17:18 ET (21:18 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}